期刊文献+

草酸铂加醛氢叶酸/5-氟尿嘧啶48h持续静脉滴注双周疗法治疗晚期直肠癌 被引量:1

Clinical study on the treatment of advanced colorectal cancer with oxaliplatin combined with regimen LF 48 hours of biweek schedule
原文传递
导出
摘要 目的观察草酸铂(L-OHP)与CF/5-FU48h持续静脉滴注双周疗法治疗晚期直肠癌疗效及不良反应。方法经病理证实的55例晚期直肠癌患者随机进入研究/对照组。治疗方案:A组草酸铂(L-OHP)+CF/5-FU;B组CF/5-FU,两组均2周为1个周期。结果经过2个周期化疗,A组缓解率33·33%(9/27),B组缓解率21·43%(6/28),A组缓解率高于B组。治疗中无疾病进展及治疗相关死亡,胃肠道反应及骨髓抑制均为轻中度,差异无显著意义。A组周围神经感觉障碍为74·0%(20/27),为轻中度可逆;B组为17·86%(5/28),两组间差异有显著意义(χ2=17·5333,P<0·001)。结论草酸铂+CF/5-FU48h持续静脉滴注双周疗法治疗晚期直肠癌疗效高,不良反应轻,有希望成为最有效的治疗方案。 Objective To assess the anti-tumor efficacy and safety of chemotherapy pump 48-hours continuous infusion treatment combined 5-fluorouracil with bi-weekly high-dose leucovorin and oxaliplatin for colorectal cancer. Methods 55 patients of advanced colorecral cancer were randomly divided into group A and B. Group A were treated with oxaliplatin with hi-weekly high-dose leucovorin and 5-fluorouracil chemotherapy pump 48-hours continuous infusion. Group B were treated with regimen LF 48 hours. All enrolled patients received two cycles of treatment. Results The effective rates of these two groups showed no marked difference ( group A 33.33 %, group B 21.43% ).Bone marrow suppression and nausea, vomiting had significant differences between two regimens. The rate of peripheral neurilemmitis response was 74.0% in group A and 17.86% in the group B(x^2= 17. 5333, P〈0.001). Conclusion Oxaliplatin with 5-fluorouracil and high-dose leucovorin is a high response regimen for advanced colorectal cancer with mild toxicity,which can be practiced safely.
出处 《中国基层医药》 CAS 2005年第7期824-825,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 草酸铂 醛氢叶酸 5-氟尿嘧啶 持续静脉滴注 双周疗法 治疗 直肠癌 Oxahplatin CF/5-fluorouracil Rectal cancer
  • 相关文献

参考文献6

二级参考文献7

共引文献445

同被引文献14

  • 1常志伟,王立东,任景丽,宋昕,郭涛,冯常炜,张延瑞,李吉林,范宗民,何欣,王苒,陈志国,郭志刚.叶酸干预对食管贲门癌前病变影响的初步研究[J].中华肿瘤防治杂志,2008,15(9):641-643. 被引量:2
  • 2梁汝坚,梁若玲,廖新勤.叶酸结合根除Hp对慢性萎缩性胃炎转归的影响[J].中国基层医药,2005,12(12):1756-1757. 被引量:3
  • 3李雄彪,马庆英,崔云龙.叶酸在肠道疾病防治中的作用[J].中国微生态学杂志,2007,19(2):238-240. 被引量:6
  • 4Giovannucci E,Stampfer M,Colditz G,et al.Multivitamin use,folate,and colon cancer in women in the Nurses′Health Study[J].Ann Inter Med,1998,129:517-524.
  • 5Sanjoaquin MA,Allen N,Couto E,et al.Folate intake and colorectal cancer risk:a meta-anlytical approach[J].Int J Cancer,2005,113:825-828.
  • 6Giovannucci E.Epidemiologic studies of folate and colorectal neoplasia:a review[J].J Nutr,2002,132(8 Suppl):S2350-S2355.
  • 7Cole BF,Baron JA,Sandler RS,et al.Folic acid for the prevention of colorectal adenomas a randanized clinical trial[J].Cancer Epidemiol Biamarkers Prev,2007,16(7):1325-1329.
  • 8Wu K,Platz EA,Willett WC,et al.A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma[J].Am J Clin Nutr,2009,90:1623-1631.
  • 9Lindzon GM,Medline A,Sohn KJ,et al.Effect of folic acid supplementation on the progression of colorectal aberrant crypt foci[J].Carcinogenesis,2009,30:1536-1543.
  • 10萧树东.胃肠病学[M].上海:上海科学技术出版社,2001.560.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部